Vis enkel innførsel

dc.contributor.authorLamu, Admassu Nadew
dc.contributor.authorNorheim, Ole Frithjof
dc.contributor.authorGregersen, Fredrik A.
dc.contributor.authorBarra, Mathias
dc.date.accessioned2022-02-03T14:22:58Z
dc.date.available2022-02-03T14:22:58Z
dc.date.created2021-10-09T17:30:33Z
dc.date.issued2021
dc.identifier.issn1057-9230
dc.identifier.urihttps://hdl.handle.net/11250/2976964
dc.description.abstractPhysical inactivity is the leading cause of non-communicable diseases, and further research on the cost-effectiveness of interventions that target inactivity is warranted. Socioeconomic status is vital in this process. We aim to evaluate the cost-effectiveness of a cycle-network expansion plan in Oslo compared to the status quo by income quintiles. We applied a Markov model using a public payer perspective. Health outcomes were measured by quality-adjusted life years (QALYs) gained from the prevention of coronary heart disease, stroke, type 2 diabetes, and cancer. We measured equity impact by the concentration index and social welfare using the achievement index. We conducted sensitivity analyses. The intervention was generally more costly and more effective than the status quo. Incremental cost per QALY falls with income quintile, ranging from $10,098 in the richest quintile to $23,053 per QALY gained in the poorest quintile. The base-case intervention increased health inequality. However, a scenario targeting low-income quintiles reduced inequality and increased social welfare. In conclusion, the cycle-network expansion is likely to be cost-effective, but with equity concerns. If decision makers care about health inequalities, the disadvantaged groups could be targeted to produce more equitable and socially desirable outcomes instead of a uniform intervention across income quintiles.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleCycle-network expansion plan in Oslo: Modeling costeffectiveness analysis and health equity impacten_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 The Authorsen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1002/hec.4435
dc.identifier.cristin1944617
dc.source.journalHealth Economicsen_US
dc.source.pagenumber3220-3235en_US
dc.relation.projectNorges forskningsråd: 260588en_US
dc.identifier.citationHealth Economics. 2021, 30 (12), 3220-3235.en_US
dc.source.volume30en_US
dc.source.issue12en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal